相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Effects of strontium ranelate on bone mass and bone turnover in women with thalassemia major-related osteoporosis
Nunziata Morabito et al.
JOURNAL OF BONE AND MINERAL METABOLISM (2016)
Klotho, a new marker for osteoporosis and muscle strength in β-thalassemia major
Alessandro Baldan et al.
BLOOD CELLS MOLECULES AND DISEASES (2015)
Effects of teriparatide retreatment in a patient with β-thalassemia major
Symeon Tournis et al.
TRANSFUSION (2015)
The Effects of Calcium Supplementation on Verified Coronary Heart Disease Hospitalization and Death in Postmenopausal Women: A Collaborative Meta-Analysis of Randomized Controlled Trials
Joshua R. Lewis et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2015)
High index of suspicion for early diagnosis of alendronate-induced stage zero osteonecrosis of jaw in thalassaemia major
Ratna Chatterjee et al.
BRITISH JOURNAL OF HAEMATOLOGY (2014)
Spine Bone Texture Assessed by Trabecular Bone Score (TBS) to Evaluate Bone Health in Thalassemia Major
M. Baldini et al.
CALCIFIED TISSUE INTERNATIONAL (2014)
Prevalence of Low Bone Mass and Vitamin D Deficiency in β-Thalassemia Major
Ploutarchos Tzoulis et al.
HEMOGLOBIN (2014)
Bisphosphonates in the management of thalassemia-associated osteoporosis: a systematic review of randomised controlled trials
Andrea Giusti
JOURNAL OF BONE AND MINERAL METABOLISM (2014)
Thalassemia Bone Disease: A 19-Year Longitudinal Analysis
Phillip Wong et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2014)
Bone Histomorphometry of Transiliac Paired Bone Biopsies After 6 or 12 Months of Treatment With Oral Strontium Ranelate in 387 Osteoporotic Women: Randomized Comparison to Alendronate
Pascale Chavassieux et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2014)
2013 Pediatric Position Development Conference: Executive Summary and Reflections
Catherine M. Gordon et al.
JOURNAL OF CLINICAL DENSITOMETRY (2014)
Health risks and benefits from calcium and vitamin D supplementation: Women's Health Initiative clinical trial and cohort study
R. L. Prentice et al.
OSTEOPOROSIS INTERNATIONAL (2013)
Thalassemia bone disease: the association between nephrolithiasis, bone mineral density and fractures
P. Wong et al.
OSTEOPOROSIS INTERNATIONAL (2013)
Vitamin D Status in Thalassemia Major: an Update
Ashraf Soliman et al.
MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES (2013)
Safety profile of drugs used in the treatment of osteoporosis: a systematical review of the literature
M. Varenna et al.
REUMATISMO (2013)
Calcium supplements and cardiovascular risk: 5 years on
Mark J. Bolland et al.
THERAPEUTIC ADVANCES IN DRUG SAFETY (2013)
Neridronate improves bone mineral density and reduces back pain in β-thalassaemia patients with osteoporosis: results from a phase 2, randomized, parallel-arm, open-label study
Gian Luca Forni et al.
BRITISH JOURNAL OF HAEMATOLOGY (2012)
Prospective study of histomorphometry, biochemical bone markers and bone densitometric response to pamidronate in β-thalassaemia presenting with osteopenia-osteoporosis syndrome
Ratna Chatterjee et al.
BRITISH JOURNAL OF HAEMATOLOGY (2012)
Immediate Administration of Zoledronic Acid Reduces Aromatase Inhibitor-Associated Bone Loss in Postmenopausal Women With Early Breast Cancer: 12-Month Analysis of the E-ZO-FAST Trial
Antonio Llombart et al.
CLINICAL BREAST CANCER (2012)
Status of 25-hydroxyvitamin D deficiency and effect of vitamin D receptor gene polymorphisms on bone mineral density in thalassemia patients of North India
Kritanjali Singh et al.
HEMATOLOGY (2012)
Safety of Osteoanabolic Therapy: A Decade of Experience
Cristiana Capriani et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2012)
A Pooled Analysis of Vitamin D Dose Requirements for Fracture Prevention
Heike A. Bischoff-Ferrari et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Inadequate Dietary Intake in Patients with Thalassemia
Ellen B. Fung et al.
JOURNAL OF THE ACADEMY OF NUTRITION AND DIETETICS (2012)
Treatment of vitamin D deficiency in transfusion-dependent thalassemia
Ellen B. Fung et al.
AMERICAN JOURNAL OF HEMATOLOGY (2011)
Use of bisphosphonates in the management of postmenopausal osteoporosis
Socrates E. Papapoulos
BISPHOSPHONATES AND OSTEONECROSIS OF THE JAW (2011)
Bone disease and skeletal complications in patients with β thalassemia major
Rachid Haidar et al.
BONE (2011)
Bone mineral density in children with beta-thalassemia major in Diyarbakir
Ayfer Gozu Pirinccioglu et al.
BONE (2011)
CLINICOPATHOLOGICAL AND RADIOLOGICAL STUDY OF EGYPTIAN beta-THALASSEMIA INTERMEDIA AND beta-THALASSEMIA MAJOR PATIENTS: RELATION TO COMPLICATIONS AND RESPONSE TO THERAPY
Galila M. Mokhtar et al.
HEMOGLOBIN (2011)
Evaluation of Growth, Puberty and Endocrine Dysfunctions in Relation to Iron Overload in Multi Transfused Indian Thalassemia Patients
Rashid H. Merchant et al.
INDIAN JOURNAL OF PEDIATRICS (2011)
The 2011 Report on Dietary Reference Intakes for Calcium and Vitamin D from the Institute of Medicine: What Clinicians Need to Know
A. Catharine Ross et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Guidelines on prevention and treatment of vitamin D deficiency
S. Adami et al.
REUMATISMO (2011)
Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis
Mark J. Bolland et al.
BMJ-BRITISH MEDICAL JOURNAL (2010)
Osteoporosis Syndrome in Thalassaemia Major: An Overview
Meropi Toumba et al.
JOURNAL OF OSTEOPOROSIS (2010)
FRAX (R) and its applications to clinical practice
John A. Kanis et al.
BONE (2009)
Differences in the prevalence of growth, endocrine and vitamin D abnormalities among the various thalassaemia syndromes in North America
Maria G. Vogiatzi et al.
BRITISH JOURNAL OF HAEMATOLOGY (2009)
Bone Disease in Thalassemia: A Frequent and Still Unresolved Problem
Maria G. Vogiatzi et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2009)
Denosumab in Men Receiving Androgen-Deprivation Therapy for Prostate Cancer
Matthew R. Smith et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
Steven R. Cummings et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Fall prevention with supplemental and active forms of vitamin D: a meta-analysis of randomised controlled trials
H. A. Bischoff-Ferrari et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
Fracture prevalence and relationship to endocrinopathy in iron overloaded patients with sickle cell disease and thalassemia
B. Fung Ellen et al.
BONE (2008)
Vitamin D deficiency, cardiac iron and cardiac function in thalassaemia major
John C. Wood et al.
BRITISH JOURNAL OF HAEMATOLOGY (2008)
Continuous improvement of bone mineral density two years post zoledronic acid discontinuation in patients with thalassemia-induced osteoporosis: long-term follow-up of a randomized, placebo-controlled trial
Ersi Voskaridou et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2008)
The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women
J. A. Kanis et al.
OSTEOPOROSIS INTERNATIONAL (2007)
Low serum levels of 25-hydroxy vitamin D in adults affected by thalassemia major or intermedia
N. Napoli et al.
BONE (2006)
Prevalence of fractures among the Thalassemia syndromes in North America
MG Vogiatzi et al.
BONE (2006)
The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis
PJ Meunier et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
New insights into the pathophysiology and management of osteoporosis in patients with beta thalassaemia
E Voskaridou et al.
BRITISH JOURNAL OF HAEMATOLOGY (2004)
分享论文
